Volume 2, Number 2 (March/April 2004)

Bench to Bedside

111

  

Clinical Status of Methylnaltrexone, A New Agent to Prevent and Manage Opioid-Induced Side Effects
Chun-Su Yuan, MD, PhD

Department of Anesthesia & Critical Care, Pritzker School of Medicine, The University of Chicago, Chicago, Illinois

With peer viewpoints by Jay R. Thomas, MD, PhD, and Charles F. von Gunten, MD, PhD, FACP, Department of Medicine, Center for Palliative Studies, San Diego Hospice & Palliative Care, San Diego, California, and Ricardo A. Cruciani, MD, PhD, Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY

abstract full text 134 kb

127

  

Cognitive Dysfunction in Patients with Small-Cell Lung Cancer: Incidence, Causes, and Suggestions on Management
Anne Kanard, MD, Stephen Frytak, MD, and Aminah Jatoi, MD

Department of Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota

With peer viewpoints by Laurie E. Gaspar, MD, Department of Radiation Oncology, University of Colorado Health Sciences Center, Denver, Colorado; Lisa R. Rogers, DO, Brain Metastasis Program, Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, Michigan; and Corey J. Langer, MD, Department of Medicine, Fox Chase Cancer Center, Philadelphia, Pennsylvania

abstract full text 119 kb

145

  

The Emerging Role and Needs of Family Caregivers in Cancer Care
Myra Glajchen, DSW

Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY

With peer viewpoints by Christine Miaskowski, RN, PhD, FAAN, Department of Physiological Nursing, University of California, San Francisco, California, and Nathan Cherny, MBBS, FRACP, Cancer Pain and Palliative Medicine Service, Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel

abstract full text 102 kb

Original Research

159

  

Palliative Treatment of Advanced Pancreatic Carcinoma in Community-Based Oncology Group Practices
H. Koeppler, MD, M. Duru, M. Grundheber, MD, J. Heymanns, MD, G. Jacobs, MD, A. Pandorf, B. Rendenbach, MD, J. Schimke, MD, and R. Weide, MD

Department of Medical Oncology, Johannes Gutenberg-University, Mainz, Germany; Praxisklinik für Hämatologie und Onkologie, Koblenz, Germany; Onkologische Schwerpunktpraxis I/II, Trier, Germany; and Onkologische Gemeinschaftspraxis, Saarbrücken, Germany

abstract full text 76 kb

How We Say It

108

  

On Medical Humanism
Celia Engel Bandman

Southwestern Vermont Regional Cancer Center and Institute of Medical Humanism, Inc., Bennington, Vermont

full text 39 kb

Commentary

166

  

Recognizing Palliative Medicine as a Subspecialty: What Does It Mean for Oncology?
Charles F. von Gunten, MD, PhD

San Diego Hospice & Palliative Care, and Moore’s Comprehensive Cancer Center, University of California, San Diego

Dale Lupu, PhD

American Board of Hospice and Palliative Medicine, Silver Spring, Maryland

full text 86 kb

How We Do It

181

  

Palliative Sedation in the Management of Refractory Symptoms
Paul Rousseau, MD

Carl T. Hayden VA Medical Center, Phoenix, Arizona

full text 75 kb

Clinical Trials

141

  

Clinical Trials in Supportive Care
Current clinical trials in the management of cancer-related cognitive dysfunction

full text 42 kb

Observations

174

  

Steroid Molecules Reverse Neutropenia in Irradiated and Platin-Treated Primates

full text 29 kb

Reader Services

99

  

Guide for Authors

© 2004 by BioLink Communictions, Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher.

The opinions expressed herein are those of the authors or advertisers. The authors, editors, and publishers make every effort to ensure that no inaccurate or misleading data, opinion, or statement is published in this journal and that drug names, dosages, and recommendations are accurate. However, readers should confirm all dosage schedules against the manufacturer’s package information data. The Publisher, Editorial Board, and their employees accept no liability whatsoever for the consequences of any inaccurate or misleading data, opinion, or statement.